CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanxi Zhendong Pharmaceutical Co Ltd Company Snapshot
Shanxi Zhendong Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi Zhendong Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Changjiang Runfa Medicine Co Ltd (2019 sales of 5.07 billion Chinese Renmimbi [US$730.35 million] of which 71% was Medicine), Shandong Lukang Pharmaceutical (3.73 billion Chinese Renmimbi [US$537.40 million] of which 72% was Human Antibiotic), and Tianjin Chase Sun Pharmaceutical Company Limited (5.00 billion Chinese Renmimbi [US$720.27 million] of which 54% was Granules).

Sales Analysis. During the year ended December of 2019, sales at Shanxi Zhendong Pharmaceutical Co Ltd were 4.40 billion Chinese Renmimbi (US$633.29 million). This is an increase of 28.6% versus 2018, when the company's sales were 3.42 billion Chinese Renmimbi. Sales of Medicinal Curb Planting saw an increase that was more than double the company's growth rate: sales were up 62.5% in 2019, from 152.25 million Chinese Renmimbi to 247.39 million Chinese Renmimbi. Not all segments of Shanxi Zhendong Pharmaceutical Co Ltd experienced an increase in sales in 2019: sales of Technology Service fell 23.4% to 54.03 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanxi Zhendong Pharmaceutical Co Ltd
  Stock Performance Chart for Shanxi Zhendong Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 6.02
(Figures in Chinese Renmimbi)
1 Week -1.6%   13 Weeks 2.7%  
4 Weeks 10.1%   52 Weeks 15.5%  
 
Shanxi Zhendong Pharmaceutical Co Ltd Key Data:
  Ticker: 300158 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 4,398,753,604
(Year Ending Jan 2020).
Employees: 3,861
  Currency: Chinese Renmimbi Market Cap: 6,185,517,853
  Fiscal Yr Ends: December Shares Outstanding: 1,027,494,660
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.